Tarek A Bismar

Tarek A Bismar

UNVERIFIED PROFILE

Are you Tarek A Bismar?   Register this Author

Register author
Tarek A Bismar

Tarek A Bismar

Publications by authors named "Tarek A Bismar"

Are you Tarek A Bismar?   Register this Author

92Publications

1430Reads

35Profile Views

Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.

J Cancer Res Clin Oncol 2019 Jul 25;145(7):1751-1759. Epub 2019 May 25.

Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02933-zDOI Listing
July 2019

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.

J Pathol 2019 Jun 17. Epub 2019 Jun 17.

Division of Urology and Cancer Research Program, McGill University Health Centre Research Institute, 1001 Decarie Blvd, Montreal, Quebec, H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5315DOI Listing
June 2019

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.

Int J Cancer 2019 May 24. Epub 2019 May 24.

Department of Pathology & Laboratory Medicine, Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32430DOI Listing
May 2019

Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification.

J Cancer Res Clin Oncol 2018 Nov 12;144(11):2117-2125. Epub 2018 Aug 12.

Brady Urological Institute, John Hopkins School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2730-5DOI Listing
November 2018

Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.

J Cancer Res Clin Oncol 2018 May 6;144(5):883-891. Epub 2018 Mar 6.

Department of Pathology and Laboratory Medicine, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2615-7DOI Listing
May 2018

Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity.

Am J Surg Pathol 2017 Oct;41(10):1299-1308

*Calgary Laboratory Services and University of Calgary ***Division of Urology, University of Calgary, Calgary, AB, Canada †Charles University, Pilsen, Czech Republic ‡Cruces University Hospital, BioCruces Institute, University of the Basque Country (UPV/EHU), Barakaldo, Bizkaia, Spain §Carregi Hospital, Florence, Italy ∥Pitié-Salpêtrière Hospital ¶Hopital Cochin, Paris ‡‡Université Lille, Lille, France #Emory University School of Medicine, Atlanta, GA **New York University Medical Center, New York, NY ††University of Arkansas for Medical Sciences, Little Rock, AR §§Barts Cancer Institute, Queen Mary University of London, London, United Kingdom ∥∥AC Camargo Cancer Center, Sao Paulo, Brazil ¶¶Diagnostico Srl Lab Pathology, Montevideo, Uruguay ##Federal University of Bahia, Faculty of Medicine of Bahia, Salvador, Brazil †††Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia ‡‡‡Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000838DOI Listing
October 2017

ING3 promotes prostate cancer growth by activating the androgen receptor.

BMC Med 2017 05 16;15(1):103. Epub 2017 May 16.

Department of Biochemistry & Molecular Biology, Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-017-0854-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434536PMC
May 2017

SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion.

Pathol Oncol Res 2017 Apr 13;23(2):399-407. Epub 2016 Oct 13.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, 7007, 14sth st sw, Calgary, AB, T2V 1P9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-016-0119-9DOI Listing
April 2017

Tubulovillous Adenoma in the Bladder in a Dual Pancreas-Kidney Transplant Patient.

J Endourol Case Rep 2017 1;3(1):17-20. Epub 2017 Feb 1.

Department of Urology, Southern Alberta Institute of Urology , Calgary, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cren.2016.0139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314996PMC
February 2017

Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.

J Mol Med (Berl) 2016 12 18;94(12):1411-1422. Epub 2016 Aug 18.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary Laboratory Services, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-016-1458-4DOI Listing
December 2016

High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.

Tumour Biol 2016 Sep 7;37(9):12287-12299. Epub 2016 Jun 7.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-016-5075-1DOI Listing
September 2016

ERG expression in prostate cancer: biological relevance and clinical implication.

J Cancer Res Clin Oncol 2016 Aug 28;142(8):1781-93. Epub 2015 Dec 28.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-2096-xDOI Listing
August 2016

ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.

Tumour Biol 2016 Jul 23;37(7):9731-8. Epub 2016 Jan 23.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-016-4802-yDOI Listing
July 2016

SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.

Urol Oncol 2016 May 22;34(5):235.e1-10. Epub 2015 Dec 22.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada; The Prostate Cancer Center, Calgary, Alberta, Canada; Departments of Oncology, Biochemistry and Molecular Biology, Calgary, Alberta, Canada; Southern Alberta Cancer Institute and Tom Baker Cancer Center, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.11.015DOI Listing
May 2016

ERG Expression in Prostate Needle Biopsy: Potential Diagnostic and Prognostic Implications.

Appl Immunohistochem Mol Morphol 2015 Aug;23(7):499-505

*Department of Pathology and Laboratory Medicine, Calgary Laboratory Services Departments of †Urology ‡Oncology, Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000119DOI Listing
August 2015

ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal.

Eur J Cell Biol 2015 May 14;94(5):214-22. Epub 2015 Mar 14.

Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Oncology, Southern Alberta Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcb.2015.03.002DOI Listing
May 2015

Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.

PLoS One 2013 31;8(12):e84261. Epub 2013 Dec 31.

Department of Computer Science, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0084261PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877262PMC
September 2014

The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.

Cancer Biol Ther 2014 Sep 27;15(9):1120-8. Epub 2014 Jun 27.

Department of Pathology and Laboratory Medicine; University of Calgary and Calgary Laboratory Services; Calgary, AB Canada; Departments of Oncology, Biochemistry and Molecular Biology; Calgary, AB Canada; Southern Alberta Cancer Institute and Tom Baker Cancer Center; Calgary, AB Canada; The Prostate Cancer Center; Calgary, AB Canada.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cbt.29689
Publisher Site
http://dx.doi.org/10.4161/cbt.29689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128855PMC
September 2014

Prostate epithelium-specific deletion of the selenocysteine tRNA gene Trsp leads to early onset intraepithelial neoplasia.

Am J Pathol 2014 Mar 18;184(3):871-7. Epub 2014 Jan 18.

McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029440130080
Publisher Site
http://dx.doi.org/10.1016/j.ajpath.2013.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936312PMC
March 2014

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis.

J Hematol Oncol 2014 Mar 7;7:21. Epub 2014 Mar 7.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-8722-7-21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975646PMC
March 2014

Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome.

BJU Int 2014 Feb 5;113(2):309-19. Epub 2013 Sep 5.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada; Department of Oncology, University of Calgary, Calgary, AB, Canada; Southern Alberta Cancer Institute and Tom Baker Cancer Center, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12262DOI Listing
February 2014

The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.

Cancer Med 2014 Feb 18;3(1):14-24. Epub 2013 Dec 18.

Segal Cancer Center and Lady Davis Institute for Medical Research, Department of Oncology and Medicine, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930386PMC
February 2014

Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells.

Exp Cell Res 2014 Jan 6;320(2):233-46. Epub 2013 Nov 6.

Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2013.10.022DOI Listing
January 2014

Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.

Cancer Epidemiol Biomarkers Prev 2013 Nov 27;22(11):1984-93. Epub 2013 Aug 27.

Authors' Affiliations: Departments of Nutrition, Epidemiology, and Biostatistics, Harvard School of Public Health; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital; Departments of Pathology and Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Molecular and Transplantation Pathology Laboratory, F. Addarii Institute of Oncology, University of Bologna, Bologna, Italy; Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia; Department of Pathology & Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta; and Departments of Medicine and Oncology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818474PMC
November 2013

Urinary bladder melanosis associated with urothelial dysplasia and invasive urothelial carcinoma: a report of two cases.

Anal Quant Cytopathol Histpathol 2013 Oct;35(5):294-300

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
October 2013

TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair.

Clin Cancer Res 2013 Sep 5;19(18):5202-9. Epub 2013 Aug 5.

Authors' Affiliations: Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; Radiation Medicine Program, Princess Margaret Hospital, University Health Network; Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; Division of Urology, University of Montreal Health Center, Montreal, Quebec; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and Department of Pathology and Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1049DOI Listing
September 2013

ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer.

ISRN Urol 2013 19;2013:786545. Epub 2013 Aug 19.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada T2V 1P9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/786545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762160PMC
September 2013

ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.

Urology 2013 Aug 6;82(2):394-9. Epub 2013 Jun 6.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.03.029DOI Listing
August 2013

Use of immunohistochemistry in routine workup of prostate needle biopsies: a tertiary academic institution experience.

Arch Pathol Lab Med 2013 Apr 28;137(4):541-5. Epub 2012 Dec 28.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services and Rockyview General Hospital, Calgary, Alberta, Canada T2V 1P9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0145-OADOI Listing
April 2013

Familial prostate cancer: the damage done and lessons learnt.

Nat Rev Urol 2013 Feb 15;10(2):116-22. Epub 2013 Jan 15.

Department of Medical Genetics, Research Institute of McGill University Health Centre, Montreal, QC H3G 1A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2012.257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913476PMC
February 2013

Protein network-based Lasso regression model for the construction of disease-miRNA functional interactions.

EURASIP J Bioinform Syst Biol 2013 Jan 22;2013(1). Epub 2013 Jan 22.

Department of Computer Science, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
https://bsb-eurasipjournals.springeropen.com/articles/10.118
Publisher Site
http://dx.doi.org/10.1186/1687-4153-2013-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606436PMC
January 2013

Detecting cancer outlier genes with potential rearrangement using gene expression data and biological networks.

Adv Bioinformatics 2012 28;2012:373506. Epub 2012 Jun 28.

Department of Computer Science, University of Calgary, Calgary, AB, Canada T2N 1N4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/373506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394389PMC
August 2012

Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells.

BJU Int 2012 Mar 19;109(5):788-95. Epub 2011 Jul 19.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10437.xDOI Listing
March 2012

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.

Histopathology 2012 Mar 19;60(4):645-52. Epub 2012 Jan 19.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, 7007 14 Street SW, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2011.04116.xDOI Listing
March 2012

ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality.

Eur J Cancer 2012 Mar 1;48(4):538-46. Epub 2012 Feb 1.

Department of Pathology and Laboratory Medicine, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.01.001DOI Listing
March 2012

PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.

Genes Chromosomes Cancer 2012 Feb 1;51(2):149-60. Epub 2011 Nov 1.

Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20939DOI Listing
February 2012

PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

Clin Cancer Res 2012 Feb 23;18(4):1015-27. Epub 2011 Nov 23.

Ontario Cancer Institute/Princess Margaret Hospital (University Health Network), University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378487PMC
February 2012

PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.

J Pathol 2011 May 7;224(1):90-100. Epub 2011 Mar 7.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2855DOI Listing
May 2011

Detection of ERG gene rearrangements and PTEN deletions in unsuspected prostate cancer of the transition zone.

Cancer Biol Ther 2011 Mar 15;11(6):562-6. Epub 2011 Mar 15.

Department of Pathology and laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.11.6.14376DOI Listing
March 2011

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.

BJU Int 2011 Feb;107(3):477-85

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09470.xDOI Listing
February 2011

Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features.

Histopathology 2010 Dec;57(6):893-906

Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2010.03726.xDOI Listing
December 2010

Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion.

J Exp Med 2010 Oct 11;207(11):2421-37. Epub 2010 Oct 11.

Lady Davis Institute for Medical Research, Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, Quebec H3T 1E2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20100433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964581PMC
October 2010

Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression.

BJU Int 2010 Aug 11;106(3):418-23. Epub 2009 Dec 11.

Department of Pathology, McGill University Health Center, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2009.09099.xDOI Listing
August 2010

'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer?

BJU Int 2010 Aug;106(3):304-15

Department of Pathology and Laboratory Medicine, Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09499.xDOI Listing
August 2010

TMPRSS2-ERG gene fusion in transition zone prostate cancer.

Mod Pathol 2010 Jul;23(7):1040-1; author reply 1041-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.89DOI Listing
July 2010

Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.

Breast Cancer Res Treat 2010 Jun 28;121(2):347-54. Epub 2009 Jul 28.

Center for Translational and Applied Genomics, British Columbia Cancer Agency, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-009-0479-x
Publisher Site
http://dx.doi.org/10.1007/s10549-009-0479-xDOI Listing
June 2010

A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.

Cancer Res 2009 Oct 6;69(20):8017-24. Epub 2009 Oct 6.

Department of Medicine, Lady Davis Institute of Medical Research, Segal Cancer Centre, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-0419DOI Listing
October 2009

Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.

Clin Cancer Res 2009 Feb;15(4):1376-83

Lady Davis Institute for Medical Research, Jewish General Hospital, Department of Oncology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/15/4/1376.full
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-1789DOI Listing
February 2009

TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.

Cancer Biol Ther 2009 Jan 4;8(2):125-30. Epub 2009 Feb 4.

Department of Pathology, McGill University and Jewish General Hospital, Montreal, QC, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.8.2.7134DOI Listing
January 2009

Early stage cancer cell invasion: signaling, biomarkers and therapeutic targeting.

Front Biosci 2008 May 1;13:6314-25. Epub 2008 May 1.

Segal Comprehensive Cancer Center, Lady Davis Institute of the Sir Mortimer B. Davis Jewish General Hospital, Department of Medicine, Faculty of Medicine, McGill University, 3755 Cote Ste-Catherine, Montreal, Canada H3T 1E2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3156DOI Listing
May 2008

Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats.

Int Urogynecol J Pelvic Floor Dysfunct 2008 Feb 17;19(2):247-52. Epub 2007 Jul 17.

Urology Department, Jewish General Hospital, McGill University, 3755 Côte Sainte-Catherine, Montreal, Quebec, Canada H3T 1E2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00192-007-0414-9DOI Listing
February 2008

ErbB-2 receptor cooperates with E6/E7 oncoproteins of HPV type 16 in breast tumorigenesis.

Cell Cycle 2007 Dec;6(23):2939-43

Montreal Center for Experimental Therapeutics in Cancer, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec H3T 1E2 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.6.23.4949DOI Listing
December 2007

Information content of five nomograms for outcomes in prostate cancer.

Am J Clin Pathol 2007 Nov;128(5):803-7

Department of Pathology, Montreal General Hospital, Montreal, Canada, and Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/XA419Q75F5D2TVJNDOI Listing
November 2007

E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells.

Cell Cycle 2007 Aug 6;6(16):2038-42. Epub 2007 Jun 6.

Program in Cancer Genetics, Oncology Department, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.6.16.4555DOI Listing
August 2007

ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas.

Future Oncol 2006 Dec;2(6):765-81

McGill University, Program in Cancer Genetics, Department of Oncology, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.2.6.765DOI Listing
December 2006

Prognostic factors in lymph node-positive prostate cancer.

Urology 2006 May;67(5):1016-21

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2005.10.055DOI Listing
May 2006

A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.

Oncogene 2005 Jul;24(29):4736-40

Lady Davis Institute for Medical Research, Jewish General Hospital and Department of Oncology, McGill University, 3755 Cote Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208572DOI Listing
July 2005

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.

Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1424-32

Department of Pathology (Amory 3-195), Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-04-0801DOI Listing
June 2005

Desmoplastic small cell tumor in the pancreas.

Am J Surg Pathol 2004 Jun;28(6):808-12

Department of Pathology, Harper University Hospital, Wayne State University, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000126782.94781.dcDOI Listing
June 2004

Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.

Pathology 2003 Dec;35(6):513-7

Department of Pathology, Harper University Hospital, Wayne State University, 3990 John R., Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020310001619910DOI Listing
December 2003

Metastatic foci of signet ring cell carcinoma in a tubular adenoma of the colon.

Arch Pathol Lab Med 2003 Nov;127(11):1509-12

Department of Pathology and Immunology, Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University School of Medicine, St Louis, Mo 63110-1093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165(2003)127<1509:MFOSRC>2.0.CO;2DOI Listing
November 2003

Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population.

Am J Surg Pathol 2003 Apr;27(4):432-40

Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200304000-00002DOI Listing
April 2003

Livebirths with placental hemorrhagic endovasculitis: interlesional relationships and perinatal outcomes.

Arch Pathol Lab Med 2002 Feb;126(2):157-64

College of Medicine, Division of Human Pathology, A-630 East Fee Hall, Michigan State University, East Lansing, MI 48824-1313, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/0003-9985(2002)126<0157:LWPHE>2.0.CO;2DOI Listing
February 2002